Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children

Objective: To evaluate the efficacy of bleomycin in the treatment of lymphatic malformations, and the concordance between photographic and radiological assessments of the outcome. Method: The retrospective study was conducted at the Vascular Anomalies Centre of Indus Hospital, Karachi, and compri...

Full description

Bibliographic Details
Main Authors: Aqsa Mazhar, Muhammad Kashif Shazlee, Yousuf Abd Mallick, Ammar Ali Muhammad, Lubna Samad
Format: Article
Language:English
Published: Pakistan Medical Association 2023-02-01
Series:Journal of the Pakistan Medical Association
Online Access:https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5623
_version_ 1797820934732644352
author Aqsa Mazhar
Muhammad Kashif Shazlee
Yousuf Abd Mallick
Ammar Ali Muhammad
Lubna Samad
author_facet Aqsa Mazhar
Muhammad Kashif Shazlee
Yousuf Abd Mallick
Ammar Ali Muhammad
Lubna Samad
author_sort Aqsa Mazhar
collection DOAJ
description Objective: To evaluate the efficacy of bleomycin in the treatment of lymphatic malformations, and the concordance between photographic and radiological assessments of the outcome. Method: The retrospective study was conducted at the Vascular Anomalies Centre of Indus Hospital, Karachi, and comprised data of patients enrolled with diagnosis of macrocystic or mixed lymphatic malformations from January 2017 to November 2019. All patients had been treated with injection bleomycin 0.6-1mg/kg/session. Size and location of lesions, ultrasonographic findings, photographic documentation and post-procedure complications were reviewed. Photographic and radiographical assessment outcomes were categorised as excellent, good or poor, and compared for concordance. Data was analysed using Stata 14. Results: Of the 31 children, 22(68.8%) were boys. Mean age at presentation was 54.2±44 months (range: 2 months to 15.7 years). There were 32 lymphatic malformations; 29(90.6) macrocystic and 3(9.4%) mixed. Head and neck region was mostly involved 19(59.4%). Most lesions 23(71.9%) presented during the first year of life, and 29(90.6%) lesions were purely macrocystic. Excellent, good and poor response was seen in 16(50%), 15(46.9%) and 1(3.1%) lesions on photographic assessment, and 21(65.6%), 11(34.4%) and 0(0.0%) lesions on radiological assessment, respectively. Concordance in photographic and radiological outcomes was 22(69%). No complications were seen and no statistically significant difference was observed for photographic and radiographic assessment with respect to gender, malformation type, region involved, and number of sessions (p>0.05). Conclusion: Intralesional bleomycin sclerotherapy was found to be effective in the treatment of lymphatic malformations. Clinical observation was reliable in assessing progress on routine follow-up, with additional radiology done when management decisions needed to be reviewed. Key Words: Bleomycin, Intralesional injection, Lymphatic malformations, Sclerotherapy.
first_indexed 2024-03-13T09:45:28Z
format Article
id doaj.art-5769bc96aa8642bc9b78862eb39b2015
institution Directory Open Access Journal
issn 0030-9982
language English
last_indexed 2024-03-13T09:45:28Z
publishDate 2023-02-01
publisher Pakistan Medical Association
record_format Article
series Journal of the Pakistan Medical Association
spelling doaj.art-5769bc96aa8642bc9b78862eb39b20152023-05-25T04:20:43ZengPakistan Medical AssociationJournal of the Pakistan Medical Association0030-99822023-02-0173210.47391/JPMA.5623Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in childrenAqsa Mazhar0Muhammad Kashif Shazlee1Yousuf Abd Mallick2Ammar Ali Muhammad3Lubna Samad4Vascular Anomallies Center Clinic, Indus Hospital and Health Network, Karachi, PakistanDepartment of Radiology, Indus Hospital and Health Network, Karachi, PakistanDepartment of Dermatology, Indus Hospital and Health Network, Karachi, PakistanInteractive Research and Development, Karachi, PakistanDepartment of Pediatric Surgery, Indus Hospital and Health Network, Karachi, Pakistan Objective: To evaluate the efficacy of bleomycin in the treatment of lymphatic malformations, and the concordance between photographic and radiological assessments of the outcome. Method: The retrospective study was conducted at the Vascular Anomalies Centre of Indus Hospital, Karachi, and comprised data of patients enrolled with diagnosis of macrocystic or mixed lymphatic malformations from January 2017 to November 2019. All patients had been treated with injection bleomycin 0.6-1mg/kg/session. Size and location of lesions, ultrasonographic findings, photographic documentation and post-procedure complications were reviewed. Photographic and radiographical assessment outcomes were categorised as excellent, good or poor, and compared for concordance. Data was analysed using Stata 14. Results: Of the 31 children, 22(68.8%) were boys. Mean age at presentation was 54.2±44 months (range: 2 months to 15.7 years). There were 32 lymphatic malformations; 29(90.6) macrocystic and 3(9.4%) mixed. Head and neck region was mostly involved 19(59.4%). Most lesions 23(71.9%) presented during the first year of life, and 29(90.6%) lesions were purely macrocystic. Excellent, good and poor response was seen in 16(50%), 15(46.9%) and 1(3.1%) lesions on photographic assessment, and 21(65.6%), 11(34.4%) and 0(0.0%) lesions on radiological assessment, respectively. Concordance in photographic and radiological outcomes was 22(69%). No complications were seen and no statistically significant difference was observed for photographic and radiographic assessment with respect to gender, malformation type, region involved, and number of sessions (p>0.05). Conclusion: Intralesional bleomycin sclerotherapy was found to be effective in the treatment of lymphatic malformations. Clinical observation was reliable in assessing progress on routine follow-up, with additional radiology done when management decisions needed to be reviewed. Key Words: Bleomycin, Intralesional injection, Lymphatic malformations, Sclerotherapy. https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5623
spellingShingle Aqsa Mazhar
Muhammad Kashif Shazlee
Yousuf Abd Mallick
Ammar Ali Muhammad
Lubna Samad
Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
Journal of the Pakistan Medical Association
title Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
title_full Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
title_fullStr Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
title_full_unstemmed Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
title_short Assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
title_sort assessment of outcomes after intralesional bleomycin sclerotherapy of lymphatic malformations in children
url https://www.ojs.jpma.org.pk/index.php/public_html/article/view/5623
work_keys_str_mv AT aqsamazhar assessmentofoutcomesafterintralesionalbleomycinsclerotherapyoflymphaticmalformationsinchildren
AT muhammadkashifshazlee assessmentofoutcomesafterintralesionalbleomycinsclerotherapyoflymphaticmalformationsinchildren
AT yousufabdmallick assessmentofoutcomesafterintralesionalbleomycinsclerotherapyoflymphaticmalformationsinchildren
AT ammaralimuhammad assessmentofoutcomesafterintralesionalbleomycinsclerotherapyoflymphaticmalformationsinchildren
AT lubnasamad assessmentofoutcomesafterintralesionalbleomycinsclerotherapyoflymphaticmalformationsinchildren